Improvement in corneal scarring following bacterial keratitis

Aim Bacterial keratitis results in corneal scarring and subsequent visual impairment. The long-term evolution of corneal scars has not been well described. In this case series, we identified patients who had improvement in corneal scarring and visual acuity from a clinical trial for bacterial kerati...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Eye (London) 2013-03, Vol.27 (3), p.443-446
Hauptverfasser: McClintic, S M, Srinivasan, M, Mascarenhas, J, Greninger, D A, Acharya, N R, Lietman, T M, Keenan, J D
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 446
container_issue 3
container_start_page 443
container_title Eye (London)
container_volume 27
creator McClintic, S M
Srinivasan, M
Mascarenhas, J
Greninger, D A
Acharya, N R
Lietman, T M
Keenan, J D
description Aim Bacterial keratitis results in corneal scarring and subsequent visual impairment. The long-term evolution of corneal scars has not been well described. In this case series, we identified patients who had improvement in corneal scarring and visual acuity from a clinical trial for bacterial keratitis. Methods We searched the records of the Steroids for Corneal Ulcers Trial (SCUT) for patients who had improvement in vision between the 3-month and 12-month visits and reviewed their clinical photographs. Results Of the 500 patients enrolled in SCUT, five patients with large central corneal scars due to bacterial keratitis are presented. All experienced improvement in rigid contact lens–corrected visual acuity from months 3 to 12. All patients also had marked improvement in corneal opacity during the same time period. None of the patients opted to have penetrating keratoplasty. Conclusions Corneal scars may continue to improve even many months after a bacterial corneal ulcer has healed. The corneal remodeling can be accompanied by considerable improvement in visual acuity, such that corneal transplantation may not be necessary.
doi_str_mv 10.1038/eye.2012.270
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3597874</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1317408897</sourcerecordid><originalsourceid>FETCH-LOGICAL-c483t-2b2854263d45c2158c29f11533439e704ee1bb2a6aa2fe62ef6ed98541b982ea3</originalsourceid><addsrcrecordid>eNqNkc9LHDEUx4NU6mp781wWeunBWZOXZJI5tFDEHwsLXlroLWSyb7bRmcmazFr8782wKqv04CEk8D755uV9CDlmdMYo16f4gDOgDGag6B6ZMKHKQgopPpAJrSQtAODPATlM6YbSXFT0IzkADlwLwSfk-7xbx3CPHfbD1PdTF2KPtp0mZ2P0_WrahLYN_8ZTbd2A0efiLUY7-MGnT2S_sW3Cz0_7Efl9cf7r7KpYXF_Oz34uCic0HwqoQUsBJV8K6YBJ7aBqGJOcC16hogKR1TXY0lposARsSlxW-QqrKw1o-RH5sc1db-oOly43G21r1tF3Nj6YYL15Xen9X7MK94bLSmklcsC3p4AY7jaYBtP55LBtbY9hkwwbB0KVKst3oEwJqnWlMvr1DXoTNrHPkxipUuUldaZOtpSLIaWIzUvfjJpRockKzajQZIUZ_7L71xf42VkGii2Q1qMhjDuv_i_wEfHipdc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1316731658</pqid></control><display><type>article</type><title>Improvement in corneal scarring following bacterial keratitis</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>SpringerLink Journals - AutoHoldings</source><creator>McClintic, S M ; Srinivasan, M ; Mascarenhas, J ; Greninger, D A ; Acharya, N R ; Lietman, T M ; Keenan, J D</creator><creatorcontrib>McClintic, S M ; Srinivasan, M ; Mascarenhas, J ; Greninger, D A ; Acharya, N R ; Lietman, T M ; Keenan, J D</creatorcontrib><description>Aim Bacterial keratitis results in corneal scarring and subsequent visual impairment. The long-term evolution of corneal scars has not been well described. In this case series, we identified patients who had improvement in corneal scarring and visual acuity from a clinical trial for bacterial keratitis. Methods We searched the records of the Steroids for Corneal Ulcers Trial (SCUT) for patients who had improvement in vision between the 3-month and 12-month visits and reviewed their clinical photographs. Results Of the 500 patients enrolled in SCUT, five patients with large central corneal scars due to bacterial keratitis are presented. All experienced improvement in rigid contact lens–corrected visual acuity from months 3 to 12. All patients also had marked improvement in corneal opacity during the same time period. None of the patients opted to have penetrating keratoplasty. Conclusions Corneal scars may continue to improve even many months after a bacterial corneal ulcer has healed. The corneal remodeling can be accompanied by considerable improvement in visual acuity, such that corneal transplantation may not be necessary.</description><identifier>ISSN: 0950-222X</identifier><identifier>EISSN: 1476-5454</identifier><identifier>DOI: 10.1038/eye.2012.270</identifier><identifier>PMID: 23238443</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>692/699 ; 692/699/255/1318 ; 692/700/565/545/576 ; Acuity ; Adult ; Aged ; Aza Compounds - therapeutic use ; Bacteria ; Case Series ; Cicatrix - physiopathology ; Clinical trials ; Cornea ; Corneal Ulcer - drug therapy ; Corneal Ulcer - microbiology ; Corneal Ulcer - physiopathology ; Evolution ; Eye ; Eye Infections, Bacterial - drug therapy ; Eye Infections, Bacterial - microbiology ; Eye Infections, Bacterial - physiopathology ; Female ; Fluoroquinolones ; Humans ; Keratitis ; Laboratory Medicine ; Male ; Medicine ; Medicine &amp; Public Health ; Middle Aged ; Ophthalmic Solutions ; Ophthalmology ; Pharmaceutical Sciences/Technology ; Pneumococcal Infections - drug therapy ; Pneumococcal Infections - microbiology ; Pneumococcal Infections - physiopathology ; Prednisolone - analogs &amp; derivatives ; Prednisolone - therapeutic use ; Pseudomonas Infections - drug therapy ; Pseudomonas Infections - microbiology ; Pseudomonas Infections - physiopathology ; Quinolines - therapeutic use ; Steroid hormones ; Surgery ; Surgical Oncology ; Ulcers ; Vision ; Vision Disorders - physiopathology ; Visual Acuity - physiology</subject><ispartof>Eye (London), 2013-03, Vol.27 (3), p.443-446</ispartof><rights>Royal College of Ophthalmologists 2013</rights><rights>Copyright Nature Publishing Group Mar 2013</rights><rights>Copyright © 2013 Royal College of Ophthalmologists 2013 Royal College of Ophthalmologists</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c483t-2b2854263d45c2158c29f11533439e704ee1bb2a6aa2fe62ef6ed98541b982ea3</citedby><cites>FETCH-LOGICAL-c483t-2b2854263d45c2158c29f11533439e704ee1bb2a6aa2fe62ef6ed98541b982ea3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3597874/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3597874/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,41464,42533,51294,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23238443$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>McClintic, S M</creatorcontrib><creatorcontrib>Srinivasan, M</creatorcontrib><creatorcontrib>Mascarenhas, J</creatorcontrib><creatorcontrib>Greninger, D A</creatorcontrib><creatorcontrib>Acharya, N R</creatorcontrib><creatorcontrib>Lietman, T M</creatorcontrib><creatorcontrib>Keenan, J D</creatorcontrib><title>Improvement in corneal scarring following bacterial keratitis</title><title>Eye (London)</title><addtitle>Eye</addtitle><addtitle>Eye (Lond)</addtitle><description>Aim Bacterial keratitis results in corneal scarring and subsequent visual impairment. The long-term evolution of corneal scars has not been well described. In this case series, we identified patients who had improvement in corneal scarring and visual acuity from a clinical trial for bacterial keratitis. Methods We searched the records of the Steroids for Corneal Ulcers Trial (SCUT) for patients who had improvement in vision between the 3-month and 12-month visits and reviewed their clinical photographs. Results Of the 500 patients enrolled in SCUT, five patients with large central corneal scars due to bacterial keratitis are presented. All experienced improvement in rigid contact lens–corrected visual acuity from months 3 to 12. All patients also had marked improvement in corneal opacity during the same time period. None of the patients opted to have penetrating keratoplasty. Conclusions Corneal scars may continue to improve even many months after a bacterial corneal ulcer has healed. The corneal remodeling can be accompanied by considerable improvement in visual acuity, such that corneal transplantation may not be necessary.</description><subject>692/699</subject><subject>692/699/255/1318</subject><subject>692/700/565/545/576</subject><subject>Acuity</subject><subject>Adult</subject><subject>Aged</subject><subject>Aza Compounds - therapeutic use</subject><subject>Bacteria</subject><subject>Case Series</subject><subject>Cicatrix - physiopathology</subject><subject>Clinical trials</subject><subject>Cornea</subject><subject>Corneal Ulcer - drug therapy</subject><subject>Corneal Ulcer - microbiology</subject><subject>Corneal Ulcer - physiopathology</subject><subject>Evolution</subject><subject>Eye</subject><subject>Eye Infections, Bacterial - drug therapy</subject><subject>Eye Infections, Bacterial - microbiology</subject><subject>Eye Infections, Bacterial - physiopathology</subject><subject>Female</subject><subject>Fluoroquinolones</subject><subject>Humans</subject><subject>Keratitis</subject><subject>Laboratory Medicine</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Middle Aged</subject><subject>Ophthalmic Solutions</subject><subject>Ophthalmology</subject><subject>Pharmaceutical Sciences/Technology</subject><subject>Pneumococcal Infections - drug therapy</subject><subject>Pneumococcal Infections - microbiology</subject><subject>Pneumococcal Infections - physiopathology</subject><subject>Prednisolone - analogs &amp; derivatives</subject><subject>Prednisolone - therapeutic use</subject><subject>Pseudomonas Infections - drug therapy</subject><subject>Pseudomonas Infections - microbiology</subject><subject>Pseudomonas Infections - physiopathology</subject><subject>Quinolines - therapeutic use</subject><subject>Steroid hormones</subject><subject>Surgery</subject><subject>Surgical Oncology</subject><subject>Ulcers</subject><subject>Vision</subject><subject>Vision Disorders - physiopathology</subject><subject>Visual Acuity - physiology</subject><issn>0950-222X</issn><issn>1476-5454</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqNkc9LHDEUx4NU6mp781wWeunBWZOXZJI5tFDEHwsLXlroLWSyb7bRmcmazFr8782wKqv04CEk8D755uV9CDlmdMYo16f4gDOgDGag6B6ZMKHKQgopPpAJrSQtAODPATlM6YbSXFT0IzkADlwLwSfk-7xbx3CPHfbD1PdTF2KPtp0mZ2P0_WrahLYN_8ZTbd2A0efiLUY7-MGnT2S_sW3Cz0_7Efl9cf7r7KpYXF_Oz34uCic0HwqoQUsBJV8K6YBJ7aBqGJOcC16hogKR1TXY0lposARsSlxW-QqrKw1o-RH5sc1db-oOly43G21r1tF3Nj6YYL15Xen9X7MK94bLSmklcsC3p4AY7jaYBtP55LBtbY9hkwwbB0KVKst3oEwJqnWlMvr1DXoTNrHPkxipUuUldaZOtpSLIaWIzUvfjJpRockKzajQZIUZ_7L71xf42VkGii2Q1qMhjDuv_i_wEfHipdc</recordid><startdate>20130301</startdate><enddate>20130301</enddate><creator>McClintic, S M</creator><creator>Srinivasan, M</creator><creator>Mascarenhas, J</creator><creator>Greninger, D A</creator><creator>Acharya, N R</creator><creator>Lietman, T M</creator><creator>Keenan, J D</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>7QL</scope><scope>C1K</scope><scope>5PM</scope></search><sort><creationdate>20130301</creationdate><title>Improvement in corneal scarring following bacterial keratitis</title><author>McClintic, S M ; Srinivasan, M ; Mascarenhas, J ; Greninger, D A ; Acharya, N R ; Lietman, T M ; Keenan, J D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c483t-2b2854263d45c2158c29f11533439e704ee1bb2a6aa2fe62ef6ed98541b982ea3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>692/699</topic><topic>692/699/255/1318</topic><topic>692/700/565/545/576</topic><topic>Acuity</topic><topic>Adult</topic><topic>Aged</topic><topic>Aza Compounds - therapeutic use</topic><topic>Bacteria</topic><topic>Case Series</topic><topic>Cicatrix - physiopathology</topic><topic>Clinical trials</topic><topic>Cornea</topic><topic>Corneal Ulcer - drug therapy</topic><topic>Corneal Ulcer - microbiology</topic><topic>Corneal Ulcer - physiopathology</topic><topic>Evolution</topic><topic>Eye</topic><topic>Eye Infections, Bacterial - drug therapy</topic><topic>Eye Infections, Bacterial - microbiology</topic><topic>Eye Infections, Bacterial - physiopathology</topic><topic>Female</topic><topic>Fluoroquinolones</topic><topic>Humans</topic><topic>Keratitis</topic><topic>Laboratory Medicine</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Middle Aged</topic><topic>Ophthalmic Solutions</topic><topic>Ophthalmology</topic><topic>Pharmaceutical Sciences/Technology</topic><topic>Pneumococcal Infections - drug therapy</topic><topic>Pneumococcal Infections - microbiology</topic><topic>Pneumococcal Infections - physiopathology</topic><topic>Prednisolone - analogs &amp; derivatives</topic><topic>Prednisolone - therapeutic use</topic><topic>Pseudomonas Infections - drug therapy</topic><topic>Pseudomonas Infections - microbiology</topic><topic>Pseudomonas Infections - physiopathology</topic><topic>Quinolines - therapeutic use</topic><topic>Steroid hormones</topic><topic>Surgery</topic><topic>Surgical Oncology</topic><topic>Ulcers</topic><topic>Vision</topic><topic>Vision Disorders - physiopathology</topic><topic>Visual Acuity - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>McClintic, S M</creatorcontrib><creatorcontrib>Srinivasan, M</creatorcontrib><creatorcontrib>Mascarenhas, J</creatorcontrib><creatorcontrib>Greninger, D A</creatorcontrib><creatorcontrib>Acharya, N R</creatorcontrib><creatorcontrib>Lietman, T M</creatorcontrib><creatorcontrib>Keenan, J D</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Eye (London)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>McClintic, S M</au><au>Srinivasan, M</au><au>Mascarenhas, J</au><au>Greninger, D A</au><au>Acharya, N R</au><au>Lietman, T M</au><au>Keenan, J D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Improvement in corneal scarring following bacterial keratitis</atitle><jtitle>Eye (London)</jtitle><stitle>Eye</stitle><addtitle>Eye (Lond)</addtitle><date>2013-03-01</date><risdate>2013</risdate><volume>27</volume><issue>3</issue><spage>443</spage><epage>446</epage><pages>443-446</pages><issn>0950-222X</issn><eissn>1476-5454</eissn><abstract>Aim Bacterial keratitis results in corneal scarring and subsequent visual impairment. The long-term evolution of corneal scars has not been well described. In this case series, we identified patients who had improvement in corneal scarring and visual acuity from a clinical trial for bacterial keratitis. Methods We searched the records of the Steroids for Corneal Ulcers Trial (SCUT) for patients who had improvement in vision between the 3-month and 12-month visits and reviewed their clinical photographs. Results Of the 500 patients enrolled in SCUT, five patients with large central corneal scars due to bacterial keratitis are presented. All experienced improvement in rigid contact lens–corrected visual acuity from months 3 to 12. All patients also had marked improvement in corneal opacity during the same time period. None of the patients opted to have penetrating keratoplasty. Conclusions Corneal scars may continue to improve even many months after a bacterial corneal ulcer has healed. The corneal remodeling can be accompanied by considerable improvement in visual acuity, such that corneal transplantation may not be necessary.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>23238443</pmid><doi>10.1038/eye.2012.270</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0950-222X
ispartof Eye (London), 2013-03, Vol.27 (3), p.443-446
issn 0950-222X
1476-5454
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3597874
source MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central; SpringerLink Journals - AutoHoldings
subjects 692/699
692/699/255/1318
692/700/565/545/576
Acuity
Adult
Aged
Aza Compounds - therapeutic use
Bacteria
Case Series
Cicatrix - physiopathology
Clinical trials
Cornea
Corneal Ulcer - drug therapy
Corneal Ulcer - microbiology
Corneal Ulcer - physiopathology
Evolution
Eye
Eye Infections, Bacterial - drug therapy
Eye Infections, Bacterial - microbiology
Eye Infections, Bacterial - physiopathology
Female
Fluoroquinolones
Humans
Keratitis
Laboratory Medicine
Male
Medicine
Medicine & Public Health
Middle Aged
Ophthalmic Solutions
Ophthalmology
Pharmaceutical Sciences/Technology
Pneumococcal Infections - drug therapy
Pneumococcal Infections - microbiology
Pneumococcal Infections - physiopathology
Prednisolone - analogs & derivatives
Prednisolone - therapeutic use
Pseudomonas Infections - drug therapy
Pseudomonas Infections - microbiology
Pseudomonas Infections - physiopathology
Quinolines - therapeutic use
Steroid hormones
Surgery
Surgical Oncology
Ulcers
Vision
Vision Disorders - physiopathology
Visual Acuity - physiology
title Improvement in corneal scarring following bacterial keratitis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T19%3A43%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Improvement%20in%20corneal%20scarring%20following%20bacterial%20keratitis&rft.jtitle=Eye%20(London)&rft.au=McClintic,%20S%20M&rft.date=2013-03-01&rft.volume=27&rft.issue=3&rft.spage=443&rft.epage=446&rft.pages=443-446&rft.issn=0950-222X&rft.eissn=1476-5454&rft_id=info:doi/10.1038/eye.2012.270&rft_dat=%3Cproquest_pubme%3E1317408897%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1316731658&rft_id=info:pmid/23238443&rfr_iscdi=true